[ad_1]
Featured news from Health
A committee of experts had recommended on Thursday to the agency that it grant authorization for the emergency use of Moderna’s COVID-19 vaccine.
The US Food and Drug Administration (FDA) finally confirmed its approval for emergency use of the Moderna laboratory vaccine. The decision was quite expected for this Friday, a day after the committee of experts recommended its approval with a landslide vote of 20-0 and two abstentions. (In context: 20 – 0 the vote to authorize Moderna’s vaccine)
President Donald Trump had already affirmed this Friday through his Twitter account that the vaccine against COVID-19 from the American laboratory Moderna had been approved, although the FDA, the body in charge of the approval, had not made the official announcement. (You may be interested: The FDA confirms the efficacy and safety of Moderna’s vaccine)
Moderna’s vaccine passed overwhelmingly. Distribution will begin immediately, ”the president tweeted.
Modern vaccine approved by overwhelming majority. Distribution to start immediately.
– Donald J. Trump (@realDonaldTrump) December 18, 2020
Vice President Mike Pence, who received an injection of the Pfizer / BioNtech vaccine minutes after Trump’s announcement, was a bit more cautious, recalling that formal product authorization from Moderna was still awaited. “We have one, and maybe in a few hours, two safe and effective vaccines against coronavirus,” he said. “When it is approved, which we hope for later today, we will be able to ship vaccines across the country next week,” he reported.
The drugmaker Moderna, a Cambridge, Massachusetts-based company that worked with researchers from the U.S. National Institute of Allergy and Infectious Diseases, has said its candidate shows an efficacy of 94.5 percent. .
[ad_2]
